BAAM
BSX icon

Baker Avenue Asset Management’s Boston Scientific BSX Stock Holding History

Baker Avenue Asset Management’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$544K Sell
8,668
-19,153
-69% -$1.53M 0.01% 402
2025
Q4 		$2.65M Buy
27,821
+1,190
+4% +$117K 0.06% 188
2025
Q3 		$2.6M Buy
26,631
+543
+2% +$56.2K 0.06% 189
2025
Q2 		$2.8M Sell
26,088
-1,410
-5% -$143K 0.08% 166
2025
Q1 		$2.77M Buy
+27,498
New +$2.77M 0.09% 171
2023
Q4 		– Sell
-167
Closed -$8.82K – 525
2023
Q3 		$8.82K Sell
167
-53
-24% -$2.78K ﹤0.01% 790
2023
Q2 		$11.9K Buy
220
+14
+7% +$731 ﹤0.01% 716
2023
Q1 		$10.3K Sell
206
-29
-12% -$1.37K ﹤0.01% 760
2022
Q4 		$10.9K Buy
+235
New +$10.2K ﹤0.01% 694
2019
Q3 		– Sell
-5,593
Closed -$240K – 240
2019
Q2 		$240K Buy
+5,593
New +$215K 0.02% 221
2017
Q2 		– Sell
-24,268
Closed -$604K – 202
2017
Q1 		$604K Buy
24,268
+1,823
+8% +$44.3K 0.08% 131
2016
Q4 		$485K Buy
22,445
+2,220
+11% +$48.4K 0.07% 149
2016
Q3 		$481K Buy
20,225
+655
+3% +$15.6K 0.07% 141
2016
Q2 		$457K Sell
19,570
-390
-2% -$8.44K 0.07% 136
2016
Q1 		$375K Sell
19,960
-3,640
-15% -$63.9K 0.06% 142
2015
Q4 		$435K Buy
+23,600
New +$423K 0.06% 128

Other funds holding BSX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Baker Avenue Asset Management's BSX Position: Q1 2026 in Review

Baker Avenue Asset Management reduced its Boston Scientific (BSX) stake by 69% in Q1 2026, selling an estimated $1.53M and leaving 8,668 shares worth $544K. The position accounts for 0.01% of the portfolio, ranked #402.

Baker Avenue Asset Management first reported a position in BSX in Q4 2015 and has held it in 16 quarters since. The position peaked at $2.8M in Q2 2025. 1,664 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

  • Baker Avenue Asset Management held 8,668 shares of Boston Scientific worth $544K as of Q1 2026.
  • Baker Avenue Asset Management sold 19,153 Boston Scientific shares in Q1 2026, an estimated $1.53M.
  • Boston Scientific made up 0.01% of Baker Avenue Asset Management's portfolio in Q1 2026, its #402 holding.
  • Baker Avenue Asset Management first reported a position in Boston Scientific in Q4 2015 and has held it in 16 quarters since.
  • Baker Avenue Asset Management's Boston Scientific position peaked at $2.8M in Q2 2025.
  • 1,664 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on Baker Avenue Asset Management's 13F filing for Q1 2026, filed 12 May 2026.